AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

5 recruiting trials

for Antisynthetase Syndrome

Optimizing Treatment on Idiopathic Inflammatory Myopathies NCT03092180n/a1 site📍 São Paulo University of Sao Paulo · Tests: Intravenous Infusion Descartes-08 in Autoantibody Myositis NCT07391605Phase 24 sites📍 Orange📍 Boston📍 Chapel Hill Cartesian Therapeutics · Tests: Descartes-08, Placebo A Study on the Efficacy and Safety of JAK Inhibitors Versus Calcineurin Inhibitors as Initial Therapy for Interstitial Lung Disease Associated With Antisynthetase Syndrome NCT07406932NA1 site📍 Beijing China-Japan Friendship Hospital · Tests: JAK Inhibitor, Calcineurin Inhibitors (CNI) BCMA-CD19 cCAR-T for the Treatment of Refractory Inflammatory Myopathy NCT07715136Phase 11 site📍 Chengdu iCell Gene Therapeutics · Tests: ICG318, BCMA-CD19-IL-15/IL-15 sushi Compound CAR-T An Exploratory Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Antisynthetase Antibody Syndrome and Rheumatoid Arthritis NCT06613490EARLY Phase 11 site📍 Nanjing The First Affiliated Hospital with Nanjing Medical Universi… · Tests: anti CD19 CAR NK cells
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy